SPAIN | ACTIS
06/11/2019
Lmite 09 Oct 2022
Oferta Tecnolgica
Ref.
TOSI20210928001
New compounds for efficient and safer cancer treatment available for license and research cooperation agreement
Researchers at a Slovenian research institute have discovered a new class of compounds for potential use in combinational chemotherapy treatments of cancer. Compounds display promising anticancer activity, along with a promise of an improved safety profile compared to established chemotherapeutics and they can be easily integrated into existing chemotherapy regimens. The partner sought is a pharmaceutical or biotechnological company for license and research cooperation agreement.
Socios

logotipo CEOE Aragnlogotipo ITAINNOVAlogotipo Cmara Toledologotipo FEDAlogotipo UCLM
logotipo FUNDECYT-PCTEX logotipo ADERlogotipo FERlogotipo AINlogotipo UNAV

06/11/2019

Requerimientos: IE 6.0+, FF 1.5+ 1024x768+ | Aviso Legal | Confidencialidad

06/11/2019